Matches in Nanopublications for { ?s ?p "[However, many patients with HNSCC respond poorly to the EGFR inhibitors (EGFRI) cetuximab and erlotinib, despite tumor expression of EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1266014.RAo4wWw46IFlNKCgwTB_IfDrzEONFuGyMdhUAMlgIDlhM130_assertion description "[However, many patients with HNSCC respond poorly to the EGFR inhibitors (EGFRI) cetuximab and erlotinib, despite tumor expression of EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266014.RAo4wWw46IFlNKCgwTB_IfDrzEONFuGyMdhUAMlgIDlhM130_provenance.